Cognitive
Show
- Alzheimer's Disease
- Seaweed Alzheimer’s Drug Approved For Clinical Trials
- This experimental drug is taking a different approach by attempting to reduce inflammation in the brain by way of altering the gut microbiome.
- 417 0
- Alzheimer's Disease
- Speeding Up Alzheimer’s Drug Testing
- “Although it’s still early days, the system raises a theoretical possibility for further development as a tool to predict who might develop Alzheimer’s."
- 501 0
- Alzheimer's Disease
- Biogen Seeking FDA Approval For Alzheimer’s Drug
- Biogen and Eisai have announced completion of the application to seek approval from the FDA for aducanumab
- 299 0
- Brain and Mental Performance
- Living in Disadvantaged Neighborhoods Increases Risk for Brain Atrophy
- The latest data suggest an association between living in a disadvantaged neighborhood and developing brain atrophy
- 301 0
-
- Alzheimer's Disease
- Seaweed Alzheimer’s Drug Approved For Clinical Trials
- This experimental drug is taking a different approach by attempting to reduce inflammation in the brain by way of altering the gut microbiome.
- 417 0
-
- Alzheimer's Disease
- Speeding Up Alzheimer’s Drug Testing
- “Although it’s still early days, the system raises a theoretical possibility for further development as a tool to predict who might develop Alzheimer’s."
- 501 0
-
- Alzheimer's Disease
- Biogen Seeking FDA Approval For Alzheimer’s Drug
- Biogen and Eisai have announced completion of the application to seek approval from the FDA for aducanumab
- 299 0
-
- Brain and Mental Performance
- Living in Disadvantaged Neighborhoods Increases Risk for Brain Atrophy
- The latest data suggest an association between living in a disadvantaged neighborhood and developing brain atrophy
- 301 0
Load More
